Department of Cardiology, Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
Department of Emergency, Chinese Medicine Hospital of Zhengzhou, Zhengzhou, Henan, China.
Biomed Pharmacother. 2017 Nov;95:1838-1843. doi: 10.1016/j.biopha.2017.08.100. Epub 2017 Oct 6.
To collect visualized proof of Tianmagouteng particles (TMGTP) in alleviating cognitive dysfunction and to explore its effects on brain activity in spontaneously hypertensive rats (SHRs) with hyperactivity of liver-yang (Gan Yang Shang Kang, GYSK).
Sixteen SHRs were randomized into treatment group and non-treatment. The SHR with GYSK was induced by gavaging aconite decoction (10mL/kg at 0.2g/mL). After the SHR models were prepared, the rats in the treatment group were administered TMGTP (10mL/kg) once a day for 14days.The rats in the non-treatment group or normal rats (control group) received an equivalent volume of saline. Morris water maze test was conducted before and after the treatment to observe cognitive function. Fluorine 18-deoxy glucose [F-18]FDG micro-PET brain imaging scans was performed after treatment. Data were analyzed with two-sample t-test (P<0. 001) using SPM2 image analysis software.
Compared with the non-treatment group, the escape latency significantly decreased but the frequency of entrance into the target zone significantly increased in the treatment group. Consistent with the alteration of cognitive functions, TMGTP induced strong brain activity in the following sites: right dorsolateral nucleus and ventrolateral nucleus of thalamus, amygdala, left met thalamus, cerebellum leaflets, original crack, front cone crack, loop-shaped leaflets; but deactivation of right medial frontal gyrus, bilateral corpus callosum, hippocampus, and left dentate gyrus.
TMGTP could alleviate cognitive dysfunction in SHRs with GYSK, which was possibly by inducing alteration of glucose metabolism in different brain regions with corresponding functions.
收集天麻颗粒(TMGTP)缓解认知功能障碍的可视化证据,并探讨其对肝阳上亢自发性高血压大鼠(SHRs)脑活动的影响。
将 16 只 SHR 随机分为治疗组和非治疗组。采用灌胃附子汤(10mL/kg,浓度为 0.2g/mL)诱导 SHR 出现肝阳上亢证。在制备 SHR 模型后,治疗组每天给予 TMGTP(10mL/kg)一次,共 14 天。非治疗组或正常大鼠(对照组)给予等体积生理盐水。治疗前后进行 Morris 水迷宫测试,观察认知功能。治疗后进行氟代脱氧葡萄糖 [F-18]FDG 微 PET 脑成像扫描。使用 SPM2 图像分析软件进行数据分析,采用双样本 t 检验(P<0.001)。
与非治疗组相比,治疗组的逃避潜伏期明显缩短,而进入目标区域的频率明显增加。与认知功能的变化一致,TMGTP 诱导以下部位的大脑活动增强:右侧背外侧核和腹外侧核、杏仁核、左侧丘脑、小脑叶片、原始裂缝、前圆锥裂缝、环形叶片;而右侧额内侧回、双侧胼胝体、海马和左侧齿状回的活性降低。
TMGTP 可缓解肝阳上亢 SHR 认知功能障碍,其可能通过诱导不同脑区葡萄糖代谢相应改变而发挥作用。